October 23, 2015 — A randomized trial found that ranolazine did not reduce the composite rate of ischemia-driven ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
October 23, 2015
October 22, 2015 — Results from the LEADERS FREE trial found that a polymer-free drug-coated stent (DCS) was superior to ...
October 22, 2015
October 20, 2015 — Results from the BRAVO 3 trial found that bivalirudin did not significantly reduce major bleeding ...
October 20, 2015
October 19, 2015 — The U.S. Food and Drug Administration (FDA) granted accelerated approval to Praxbind (idarucizumab) ...
October 19, 2015
October 2, 2015 — AstraZeneca announced that Brilinta (ticagrelor) 60-mg tablets are now available in U.S. pharmacies ...
October 02, 2015September 25, 2015 – The Icahn School of Medicine at Mount Sinai has launched the international TWILIGHT clinical trial ...
September 25, 2015
September 15, 2015 — AstraZeneca announced that the U.S. Food and Drug Administration (FDA) has approved Brilinta ...
September 15, 2015
September 11, 2015 — New Haven Pharmaceuticals Inc. announced U.S. Food and Drug Administration (FDA) approval of ...
September 11, 2015September 8, 2015 — Extending clot-preventing dual antiplatelet therapy (DAPT) beyond the recommended 12 months after ...
September 08, 2015
September 4, 2015 — Janssen Pharmaceuticals Inc. and its development partner Bayer HealthCare announced results from ...
September 04, 2015
September 1, 2015 — Extending treatment with the anticoagulant bivalirudin for at least four hours after completion of ...
September 01, 2015
August 26, 2014 — The Cardiovascular Research Foundation (CRF) announced the late-breaking trials and first report ...
August 26, 2015
August 12, 2015 — The National Institute for Health and Care Excellence (NICE) has recommended a new treatment to help ...
August 12, 2015
August 5, 2015 — Boehringer Ingelheim announced the first U.S. patients have been enrolled in two of the company's ...
August 05, 2015
August 4, 2015 — Triple therapy is no better than dual antiplatelet therapy in preventing major adverse cardiac events ...
August 04, 2015© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now